Back to search

Michigan Technological University

Exploring Fructose Mimetics as Chemotherapeutic Potentiators: Impact on GLUT5-Mediated Cancer Cell Vulnerability

Abstract

dc:description.abstract

Metabolic reprogramming toward increased sugar uptake is a hallmark of cancer, and fructose-specific uptake through the facilitative transporter GLUT5 is selectively upregulated in several adenocarcinomas, including breast and lung cancer. This dissertation develops and characterizes a panel of fluorescent fructose mimetics – the coumarin-based ManCou probes and the quinolinone-based ManQuin probes – as GLUT5-targeted reporters, cytotoxic effectors, and chemosensitization adjuvants, and establishes the boundaries within which each role holds. The central experimental strategy pairs each GLUT5-targeted glycoconjugate with its sugar-free aglycone control, isolating transporter-mediated cytotoxicity from cytotoxicity intrinsic to the fluorophore itself. In luminal (MCF7) and triple-negative (MDA-MB-231) breast carcinoma, the GLUT5-targeted ManCou conjugates produce durable, phenotype-scaled cytotoxicity that exceeds and outlasts that of the matched aglycones, while relatively sparing normal fibroblasts and defining a therapeutic window. The transport-restricting conjugate ManCou-Ph and the quinoline ManQuin-5 additionally sensitize triple-negative lines to the DNA-damaging agents oxaliplatin and cyclophosphamide at sub-cytotoxic concentrations, with the benefit confined to the sub-saturating dose range of each chemotherapeutic. In A549 lung adenocarcinoma, this relationship inverts: the GLUT5-targeted conjugates are inert across the tested concentration range, while the sugar-free aglycones – particularly the unsubstituted coumarin – produce marked, time-dependent cytotoxicity. This dissociation, further tested using the differently-selective ManQuin probes, identifies a tissue-level boundary on the conjugate-driven mechanism rather than a failure of GLUT5 routing, and reframes A549 cytotoxicity as intrinsic to the fluorophore rather than transporter-mediated. Across all phenotypes, the ManQuin probes maintain low intrinsic cytotoxicity through 72 hours of continuous exposure and impose no latent or post-washout toxicity, validating their use as non-perturbing reporters of GLUT5 activity independent of their role as effectors elsewhere in the panel. Together, these results establish a matched aglycone-conjugate framework for isolating GLUT5-mediated effects from off-target fluorophore activity and demonstrate that a single probe scaffold can serve three distinct roles, reporter, effector, and chemosensitization adjuvant, with the operative role determined by cell-line phenotype and by which structural feature of the probe is engaged.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy in Biochemistry and Molecular Biology (PhD)
Level thesis:degree_level
Open Access Dissertation
Discipline thesis:degree_discipline
Department of Chemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Buwa, Vedant
Committee members dc:contributor.committeemember
  • Tarun Dam
  • Mark Tang
  • Robert Larson
Contributors dc:contributor
  • Marina Tanasova
  • Smitha Rao-Hatti

Subjects

dc:subject × 1

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Michigan Technological University
Base URL
digitalcommons.mtu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Buwa, Vedant. Exploring Fructose Mimetics as Chemotherapeutic Potentiators: Impact on GLUT5-Mediated Cancer Cell Vulnerability. Open Access Dissertation thesis, https://doi.org/10.37099/mtu.dc.etdr/2130